BNP Paribas Financial Markets’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-56,365
| Closed | -$5.75M | – | 3340 |
|
2023
Q2 | $5.75M | Buy |
56,365
+22,601
| +67% | +$2.3M | 0.01% | 827 |
|
2023
Q1 | $3.07M | Buy |
33,764
+4,481
| +15% | +$407K | ﹤0.01% | 1130 |
|
2022
Q4 | $1.11M | Sell |
29,283
-32,367
| -53% | -$1.23M | ﹤0.01% | 1524 |
|
2022
Q3 | $1.55M | Sell |
61,650
-20,322
| -25% | -$511K | ﹤0.01% | 1588 |
|
2022
Q2 | $2.49M | Buy |
81,972
+24,938
| +44% | +$758K | ﹤0.01% | 1165 |
|
2022
Q1 | $1.87M | Buy |
57,034
+22,592
| +66% | +$740K | ﹤0.01% | 1420 |
|
2021
Q4 | $908K | Buy |
34,442
+12,483
| +57% | +$329K | ﹤0.01% | 2080 |
|
2021
Q3 | $2.21M | Buy |
21,959
+15,989
| +268% | +$1.61M | ﹤0.01% | 1366 |
|
2021
Q2 | $845K | Buy |
5,970
+4,841
| +429% | +$685K | ﹤0.01% | 1756 |
|
2021
Q1 | $113K | Buy |
1,129
+328
| +41% | +$32.7K | ﹤0.01% | 2745 |
|
2020
Q4 | $99K | Buy |
801
+321
| +67% | +$39.7K | ﹤0.01% | 2568 |
|
2020
Q3 | $46.8K | Sell |
480
-6,393
| -93% | -$623K | ﹤0.01% | 2872 |
|
2020
Q2 | $1.07M | Sell |
6,873
-639
| -9% | -$99.7K | ﹤0.01% | 1280 |
|
2020
Q1 | $1.08M | Buy |
7,512
+4,340
| +137% | +$626K | ﹤0.01% | 1380 |
|
2019
Q4 | $648K | Sell |
3,172
-510
| -14% | -$104K | ﹤0.01% | 1694 |
|
2019
Q3 | $296K | Buy |
3,682
+1,121
| +44% | +$90K | ﹤0.01% | 1924 |
|
2019
Q2 | $242K | Sell |
2,561
-1,824
| -42% | -$172K | ﹤0.01% | 1903 |
|
2019
Q1 | $375K | Buy |
4,385
+4,207
| +2,363% | +$360K | ﹤0.01% | 1743 |
|
2018
Q4 | $9.99K | Sell |
178
-589
| -77% | -$33K | ﹤0.01% | 2681 |
|
2018
Q3 | $62.7K | Buy |
767
+184
| +32% | +$15K | ﹤0.01% | 2304 |
|
2018
Q2 | $20.4K | Sell |
583
-1,873
| -76% | -$65.5K | ﹤0.01% | 2845 |
|
2018
Q1 | $50.4K | Buy |
2,456
+44
| +2% | +$902 | ﹤0.01% | 2982 |
|
2017
Q4 | $68.3K | Buy |
2,412
+1,559
| +183% | +$44.2K | ﹤0.01% | 2846 |
|
2017
Q3 | $26.5K | Sell |
853
-72
| -8% | -$2.24K | ﹤0.01% | 2949 |
|
2017
Q2 | $29.3K | Buy |
925
+840
| +988% | +$26.6K | ﹤0.01% | 2941 |
|
2017
Q1 | $1.93K | Sell |
85
-190
| -69% | -$4.3K | ﹤0.01% | 2981 |
|
2016
Q4 | $6K | Sell |
275
-120
| -30% | -$2.62K | ﹤0.01% | 3060 |
|
2016
Q3 | $10.4K | Buy |
395
+170
| +76% | +$4.48K | ﹤0.01% | 3157 |
|
2016
Q2 | $4.44K | Buy |
+225
| New | +$4.44K | ﹤0.01% | 3312 |
|